- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | HeartBeam receives patent for multi-modal cardiac sensing device | 1 | Investing.com | ||
| 02.07. | HeartBeam, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.06. | HeartBeam, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 22.05. | H.C. Wainwright cuts Heartbeam stock price target on slower sales ramp | 1 | Investing.com | ||
| 15.05. | Benchmark cuts Heartbeam stock price target on dilution to $5 | 1 | Investing.com | ||
| 13.05. | Earnings Call: HeartBeam übertrifft EPS-Prognose für Q1 2026 - Aktie legt nachbörslich zu | 2 | Investing.com Deutsch | ||
| 13.05. | HeartBeam Q1 2026 Earnings Call: Complete Transcript | 4 | Benzinga.com | ||
| 13.05. | HeartBeam GAAP EPS of -$0.12 beats by $0.02 | 1 | Seeking Alpha | ||
| HEARTBEAM Aktie jetzt für 0€ handeln | |||||
| 13.05. | HeartBeam, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 11.05. | HeartBeam starts pilot study of on-demand 12-lead ECG patch | - | MassDevice | ||
| 24.04. | HeartBeam (BEAT): 10 Best NASDAQ Growth Stocks to Buy and Hold Forever | 16 | Insider Monkey | ||
| 20.04. | Heartbeam: D. Boral Capital stuft Aktie wegen Konditionen der Kapitalerhöhung herab | 16 | Investing.com Deutsch | ||
| 20.04. | D. Boral Capital cuts Heartbeam stock rating on capital raise terms | 1 | Investing.com | ||
| 16.04. | HeartBeam closes $10M public offering for product rollout | 1 | Investing.com | ||
| 16.04. | HeartBeam, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.04. | HeartBeam slips 12%, prices $10M stock offering | 4 | Seeking Alpha | ||
| 15.04. | HeartBeam prices $10M public offering at $0.80 per share | 1 | Investing.com | ||
| 14.04. | HeartBeam announces stock offering; shares drop 18% after-hours | 1 | Seeking Alpha | ||
| 14.04. | HeartBeam kündigt öffentliches Angebot von Stammaktien an | 1 | Investing.com Deutsch | ||
| 14.04. | HeartBeam launches public offering of common stock | 1 | Investing.com |
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 13,950 | -1,34 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| UNITEDHEALTH | 373,40 | +0,86 % | Ihre wichtigsten Termine: Zahlenbereicht von: Netflix, Alcoa, United Airlines und Abbott Laboratories | © Foto: Netflix MediaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine 00:30 Uhr... ► Artikel lesen | |
| THERMO FISHER | 475,00 | +0,68 % | Thermo Fisher Scientific declares $0.47 dividend | ||
| DEXCOM | 68,20 | 0,00 % | Neue Maßstäbe bei der kontinuierlichen Zuckermessung speziell für Menschen mit Typ-2-Diabetes: / Neuer Sensor Dexcom Flex ab heute in Deutschland verfügbar | Mainz (ots) - - Dexcom gibt Markteinführung eines neuen Sensors zur kontinuierlichen Zuckermessung bekannt: Dexcom Flex. - Der Sensor wurde speziell für Menschen mit Typ-2-Diabetes entwickelt, die mit... ► Artikel lesen | |
| HEALWELL AI | 0,439 | +2,81 % | HEALWELL AI: HEALWELL AI Announces Voting Results of 2026 AGSM | Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,080 | -0,95 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds | $4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrants
SEATTLE, June 12, 2026 /PRNewswire/... ► Artikel lesen | |
| LIFEWARD | 7,740 | -1,28 % | Lifeward Ltd.: Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing | HUDSON, Mass. and YOKNEAM ILLIT, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| IMUNON | 1,600 | -10,61 % | Celsion Bank wird Mitglied des Liechtensteinischen Bankenverbandes | Vaduz - Die Celsion Bank AG ist seit 1. Juli 2026 Vollmitglied des Liechtensteinischen Bankenverbandes (LBV). Die Celsion Bank bringt ein klares Profil mit Fokus auf digitale Vermögenswerte ein und... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 44,200 | -0,90 % | Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance | First quarter revenue growth of 1.6%First quarter diluted EPS of $(0.39); adjusted diluted EPS of $0.10First quarter operating cash flow of $12.8 million MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| INSPIREMD | 0,545 | 0,00 % | InspireMD Inc.: InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures | MIAMI, June 08, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced... ► Artikel lesen | |
| GT BIOPHARMA | 0,389 | +1,36 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| INOGEN | 5,750 | +3,60 % | Inogen appoints Andy Reding as chief operating officer | ||
| MYOMO | 0,928 | 0,00 % | MYOMO, INC. - 8-K, Current Report | ||
| INTELLIGENT BIO SOLUTIONS | 2,230 | +1,36 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry | Interference Study designed to validate system specificity in the presence of potentially interfering substances commonly encountered in real-world settings Company expects to complete the study by... ► Artikel lesen | |
| CATHETER PRECISION | 0,628 | -1,83 % | Catheter Precision, Inc. - 8-K, Current Report |
HEARTBEAM INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,001 (-0,12 %) liegt der Kurs bei 0,575 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HEARTBEAM INC finden Sie auf Wallstreet Online.